[Aldosterone antagonists: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
Yamamoto
Takeshi
T
Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine.
D000450:Aldosterone / Q000502:physiology; D002908:Chronic Disease; D000075202:Contraindications; D000077545:Eplerenone; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D015996:Survival Rate
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone